Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | SVP, Clinical Solutions | July 22, 2026 | July 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QUEST DIAGNOSTICS INC
Report date July 22, 2026 · Filed July 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,557 |
Reported balance
After 2026-07-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-22 · Other · Acquired 37 · Balance 13,557 F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 358 |
Reported balance
Holding disclosure · report date 2026-07-22 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 358 |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 1,691 |
Reported balance
Holding disclosure · report date 2026-07-22 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,691 F3: These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
F2: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
F3: These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 22, 2026 Filed Jul 27, 2026 20:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 37 | $206.81 | $7,651.86 |
DisclosureSEC source: 0001022079-26-000086 · wk-form4_1785184536.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,557 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 20:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 4,827 | $121.81 Strike: $121.81 | $587,952.74 |
DisclosureSEC source: 0001022079-26-000053 · wk-form4_1780950744.xml · derivative · entry 7 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,827 shares Expires 2031-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 17, 2022, the second on February 17, 2023 and the final on February 17, 2024. Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 20:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 3,320 | $127.73 Strike: $127.73 | $424,047.00 |
DisclosureSEC source: 0001022079-26-000053 · wk-form4_1780950744.xml · derivative · entry 6 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,320 shares Expires 2032-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F4 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 24, 2023, the second on February 24, 2024 and the final on February 24, 2025. Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 20:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 8,147 | $200.00 | $1,629,400.00 |
DisclosureSEC source: 0001022079-26-000053 · wk-form4_1780950744.xml · nonDerivative · entry 3 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,510 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 20:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 4,827 | $121.81 | $587,952.74 |
DisclosureSEC source: 0001022079-26-000053 · wk-form4_1780950744.xml · nonDerivative · entry 2 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 20:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 3,320 | $127.73 | $424,047.00 |
DisclosureSEC source: 0001022079-26-000053 · wk-form4_1780950744.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| April 20, 2026 Filed Apr 24, 2026 22:23 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 39 | $194.70 | $7,593.26 |
DisclosureSEC source: 0001022079-26-000045 · wk-form4_1777069399.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,490 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:43 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 2,628 | $204.86 | $538,372.08 |
DisclosureSEC source: 0001022079-26-000025 · wk-form4_1772833398.xml · nonDerivative · entry 2 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,441 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:43 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 6,200 | $204.86 | $1,270,132.00 |
DisclosureSEC source: 0001022079-26-000025 · wk-form4_1772833398.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,069 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 205 | $204.86 | $41,996.30 |
DisclosureSEC source: 0001022079-26-000019 · wk-form4_1772660268.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,869 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 9,853 | $0.00 Strike: $204.96 | $0.00 |
DisclosureSEC source: 0001955217-26-000002 · wk-form4_1771625442.xml · derivative · entry 7 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,853 Underlying: Common Stock · 9,853 shares Expires 2036-02-18 F6 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 2,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001955217-26-000002 · wk-form4_1771625442.xml · nonDerivative · entry 3 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,049 F2 · security: Represents an award of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 259 | $206.99 | $53,610.41 |
DisclosureSEC source: 0001955217-26-000002 · wk-form4_1771625442.xml · nonDerivative · entry 2 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,914 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 252 | $210.01 | $52,922.52 |
DisclosureSEC source: 0001955217-26-000002 · wk-form4_1771625442.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,173 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| January 28, 2026 Filed Feb 20, 2026 22:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 16 | $183.52 | $2,936.26 |
DisclosureSEC source: 0001955217-26-000002 · wk-form4_1771625442.xml · nonDerivative · entry 4 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,065 F3 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F4 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| October 21, 2025 Filed Oct 24, 2025 22:11 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 15 | $189.08 | $2,836.14 |
DisclosureSEC source: 0001022079-25-000229 · wk-form4_1761343868.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,379 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 21:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 123 | $175.91 | $21,636.93 |
DisclosureSEC source: 0001955217-25-000005 · wk-form4_1755293154.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,338 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| July 31, 2025 Filed Aug 1, 2025 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 2,210 | $170.00 | $375,700.00 |
DisclosureSEC source: 0001022079-25-000195 · wk-form4_1754080639.xml · nonDerivative · entry 7 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,450 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| July 30, 2025 Filed Aug 1, 2025 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 5,224 | $112.17 Strike: $112.17 | $585,976.08 |
DisclosureSEC source: 0001022079-25-000195 · wk-form4_1754080639.xml · derivative · entry 9 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,224 shares Expires 2030-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F4 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 18, 2021, the second on February 18, 2022 and the final on February 18, 2023. Read SEC document |
| July 30, 2025 Filed Aug 1, 2025 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 3,045 | $86.63 Strike: $86.63 | $263,788.35 |
DisclosureSEC source: 0001022079-25-000195 · wk-form4_1754080639.xml · derivative · entry 8 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,045 shares Expires 2029-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F3 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 18, 2020, the second on February 18, 2021 and the final on February 18, 2022. Read SEC document |
| July 30, 2025 Filed Aug 1, 2025 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 5,224 | $167.40 | $874,497.60 |
DisclosureSEC source: 0001022079-25-000195 · wk-form4_1754080639.xml · nonDerivative · entry 4 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,660 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| July 30, 2025 Filed Aug 1, 2025 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 5,224 | $112.17 | $585,976.08 |
DisclosureSEC source: 0001022079-25-000195 · wk-form4_1754080639.xml · nonDerivative · entry 3 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| July 30, 2025 Filed Aug 1, 2025 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 3,045 | $167.40 | $509,733.00 |
DisclosureSEC source: 0001022079-25-000195 · wk-form4_1754080639.xml · nonDerivative · entry 2 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,660 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| July 30, 2025 Filed Aug 1, 2025 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 3,045 | $86.63 | $263,788.35 |
DisclosureSEC source: 0001022079-25-000195 · wk-form4_1754080639.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| July 21, 2025 Filed Jul 25, 2025 20:28 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 27 | $167.50 | $4,522.45 |
DisclosureSEC source: 0001022079-25-000187 · wk-form4_1753475272.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,660 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| April 21, 2025 Filed May 2, 2025 20:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 27 | $164.42 | $4,439.39 |
DisclosureSEC source: 0001022079-25-000129 · wk-form4_1746217961.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,612 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| April 02, 2025 Filed Apr 5, 2025 00:26 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 2,555 | $170.00 | $434,350.00 |
DisclosureSEC source: 0001022079-25-000107 · wk-form4_1743812807.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,575 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,879 | $173.74 | $326,457.46 |
DisclosureSEC source: 0001022079-25-000089 · wk-form4_1741210599.xml · nonDerivative · entry 3 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,119 F3 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F4 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 4,434 | $173.74 | $770,363.16 |
DisclosureSEC source: 0001022079-25-000089 · wk-form4_1741210599.xml · nonDerivative · entry 2 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,998 F2 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 992 | $173.74 | $172,350.08 |
DisclosureSEC source: 0001022079-25-000089 · wk-form4_1741210599.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,564 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 233 | $171.75 | $40,017.75 |
DisclosureSEC source: 0001022079-25-000072 · wk-form4_1740778570.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,546 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 21:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 287 | $169.71 | $48,706.77 |
DisclosureSEC source: 0001022079-25-000054 · wk-form4_1740174125.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,779 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:28 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 8,702 | $0.00 Strike: $165.30 | $0.00 |
DisclosureSEC source: 0001022079-25-000034 · wk-form4_1739572073.xml · derivative · entry 4 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,702 Underlying: Common Stock · 8,702 shares Expires not disclosed F4 · derivative.expiration_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:28 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 2,269 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-25-000034 · wk-form4_1739572073.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,066 F1 · security: Represents an award of restricted stock units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:29 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 12 | $158.03 | $1,896.41 |
DisclosureSEC source: 0001022079-25-000015 · wk-form4_1738358968.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,780 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| October 28, 2024 Filed Oct 30, 2024 20:26 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,775 | $156.92 | $278,525.19 |
DisclosureSEC source: 0001022079-24-000202 · wk-form4_1730319974.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,734 F1 · price: This transaction was executed in multiple trades at prices ranging from $156.830 to $156.9156. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 21, 2024 Filed Oct 25, 2024 20:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 21 | $149.37 | $3,136.77 |
DisclosureSEC source: 0001022079-24-000197 · wk-form4_1729887947.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,509 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| August 28, 2024 Filed Aug 29, 2024 20:45 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,990 | $153.26 | $304,989.79 |
DisclosureSEC source: 0001022079-24-000174 · wk-form4_1724964130.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,459 F1 · price: This transaction was executed in multiple trades at prices ranging from $153.2557 to $153.310. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 21:01 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 74 | $149.46 | $11,060.04 |
DisclosureSEC source: 0001022079-24-000170 · wk-form4_1723842081.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,449 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| July 22, 2024 Filed Jul 26, 2024 22:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 31 | $146.97 | $4,556.16 |
DisclosureSEC source: 0001022079-24-000166 · wk-form4_1722033137.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,511 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| April 29, 2024 Filed May 1, 2024 20:26 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,760 | $140.00 | $246,400.00 |
DisclosureSEC source: 0001022079-24-000109 · wk-form4_1714595185.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,435 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| April 22, 2024 Filed Apr 26, 2024 21:44 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 45 | $126.25 | $5,681.07 |
DisclosureSEC source: 0001022079-24-000106 · wk-form4_1714167884.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,195 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:49 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 68 | $126.36 | $8,592.48 |
DisclosureSEC source: 0001022079-24-000082 · wk-form4_1709329744.xml · nonDerivative · entry 2 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,124 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:49 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 205 | $126.36 | $25,903.80 |
DisclosureSEC source: 0001022079-24-000082 · wk-form4_1709329744.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,192 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 619 | $125.02 | $77,387.38 |
DisclosureSEC source: 0001022079-24-000063 · wk-form4_1709069533.xml · nonDerivative · entry 2 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,397 F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 2,039 | $125.02 | $254,915.78 |
DisclosureSEC source: 0001022079-24-000063 · wk-form4_1709069533.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,016 F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2021, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 102 | $125.02 | $12,752.04 |
DisclosureSEC source: 0001022079-24-000051 · wk-form4_1708723984.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,977 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 01:03 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 11,007 | $0.00 Strike: $127.81 | $0.00 |
DisclosureSEC source: 0001022079-24-000031 · wk-form4_1708131777.xml · derivative · entry 4 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,007 Underlying: Common Stock · 11,007 shares Expires 2034-02-14 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 01:03 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 2,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-24-000031 · wk-form4_1708131777.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,079 F1 · security: Represents an award of restricted share units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 29 | $129.33 | $3,750.45 |
DisclosureSEC source: 0001022079-24-000013 · wk-form4_1706909795.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,438 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.